Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Jonae Barnes - Senior Vice President, Investor Relations and Corporate Communications Jean-Pierre Sommadossi - Founder, Chairman and CEO Janet Hammond - Chief Development Officer Andrea Corcoran - Chief Financial Officer and Executive President, Legal John Vavricka - Chief Commercial Officer Conference Call Participants Eric Joseph - J.P. Morgan Matthew Harrison - Morgan Stanley Jonathan Mi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission File Number: 001-39661 ATEA PHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter) Delaw ...